{
    "clinical_study": {
        "@rank": "58666", 
        "arm_group": {
            "arm_group_label": "embolisations, uterine fibroid", 
            "arm_group_type": "Other", 
            "description": "embolisation interventions with microparticles"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether two different embolisation techniques are\n      equally  effective, or is there any difference between the two techniques in the treatment\n      of the uterine fibroid  controlled with MR examination. Diffusion weighted  MR imaging\n      before intervention and  3 months and 12 months after interventions will be analyse as\n      potential predictor  of volumetric response after embolization.\n\n      Another purpose  is to determine long-term follow up in all patient treated in period from\n      2001-2011 in OUH  analysed retrospectively."
        }, 
        "brief_title": "Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Uterine Fibroids", 
            "Arterial Embolization"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Leiomyoma", 
                "Myofibroma"
            ]
        }, 
        "detailed_description": {
            "textblock": "60 patients randomise in the two groups each group consist of the 30 patients. Group 1: 30\n      patients treat with Bead-block  microparticles, 700-900\u00b5m until flowstop ( \" cut the  tree\"\n      appearance) .\n\n      Group 2: 30 patient treat with  Bead-block microparticles, combinations of the  1ml -500-700\n      \u00b5m particle, if a.uterine is  < 3 mm,  follow by  700-900 \u00b5m particle until blood flowstop\n      or  with 2 ml -500-700 \u00b5m particle if arteria uterine has diameter of > 3 mm follow by\n      embolisation with  700-900 \u00b5m particle until blood flowstop ( \" cut the  tree\" appearance ).\n\n      Clinical and technical success as well as clinical  and radiological follow up after 3 and\n      12 months. MR of the pelvis  examination with contrast, 3 and 12 month after intervention to\n      define and  control infraction degree.\n\n      Diffusion weighted imaging- DWI for and after intervention with main goal to examine\n      eventually potential of DWI and apparent diffusion coefficient  as predictor of volumetric\n      response of uterine fibroid  in a prospective group.\n\n      Retrospective study compromised all patient treated between January  2001 until january 2011\n      with follow up to January 2014,  and re-intervention  as well as complications rate\n      analysis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  symptomatic uterus fibroma\n\n        Exclusion Criteria:\n\n          -  pelvic  infection (cystitis, oophoritis, salpingitis, abscess, urethritis)\n\n          -  gravidity\n\n          -  uterus malignancy\n\n          -  big subserosal  fibroma with stalk diameter of  <2 cm\n\n          -  menopausal women\n\n          -  don,t want to be included into the study\n\n               -  concomitant adenomyosis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "52 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852734", 
            "org_study_id": "OUH-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "embolisations, uterine fibroid", 
                "description": "Comparison between the two techniques. First group will be treated only with microparticles 700- 900  until flowstop and second group depends on diameter of the uterine artery with combinations of 500-700 + 700-900 microparticles. If arteria uterine is > 3mm in diameter  combination of 2ml 500-700 and 700-900 particles until flowstop will be used and if arteria uterine has diameter < 3 mm combination of 1 ml 500-700 + 700-900 microparticles until flow stop will be used.", 
                "intervention_name": "embolisations ,uterine fibroid", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "embolisations, uterine fibroid", 
                "description": "comparison between two embolisation techniques", 
                "intervention_name": "embolisations", 
                "intervention_type": "Procedure", 
                "other_name": "microparticles, uterine fibroid"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "duvnjak.stevo@gmail.com", 
                    "last_name": "Stevo Duvnjak, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark", 
                        "state": "Fyn", 
                        "zip": "5000"
                    }, 
                    "name": "Odense University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "duvnjak.stevo@gmail.com", 
                    "last_name": "Stevo Duvnjak, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark", 
                        "zip": "5000"
                    }, 
                    "name": "Odense University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "official_title": "Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives", 
        "overall_contact": {
            "email": "duvnjak.stevo@gmail.com", 
            "last_name": "Stevo Duvnjak, MD, EBIR", 
            "phone": "+4551308867"
        }, 
        "overall_official": {
            "affiliation": "Odense University Hospital", 
            "last_name": "Stevo Duvnjak, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary goal is to achieve release of symptoms after intervention and it would be compared between the two techniques", 
            "measure": "clinical effect", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852734"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Odense University Hospital", 
            "investigator_full_name": "Stevo Duvnjak,MD", 
            "investigator_title": "Medical Doctor, Radiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "reinterventions rate", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "source": "Odense University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Odense University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}